1. Home
  2. Analysis
  3. Sulfatrim
  4. Naprosyn

Sulfatrim and Naprosyn drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Sulfatrim and Naprosyn. Common interactions include nausea among females and myocardial infarction among males.

The phase IV clinical study analyzes what interactions people who take Sulfatrim and Naprosyn have. It is created by eHealthMe based on reports of 42 people who take Sulfatrim and Naprosyn from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On May, 26, 2023

42 people who take Sulfatrim and Naprosyn together, and have interactions are studied.

What is Sulfatrim?

Sulfatrim has active ingredients of sulfamethoxazole; trimethoprim. eHealthMe is studying from 2,969 Sulfatrim users for its effectiveness, alternative drugs and more.

What is Naprosyn?

Naprosyn has active ingredients of naproxen. It is often used in pain. eHealthMe is studying from 15,946 Naprosyn users for its effectiveness, alternative drugs and more.

Number of Sulfatrim and Naprosyn reports submitted per year:

Sulfatrim and Naprosyn drug interactions.

Common Sulfatrim and Naprosyn drug interactions by gender *:

female:

  1. Nausea
  2. Pharyngitis
  3. Vomiting
  4. Weight decreased
  5. Abdominal discomfort
  6. Feeding disorder
  7. Musculoskeletal disorder
  8. Abdominal pain upper
  9. Arthropathy
  10. Drug hypersensitivity

male:

  1. Myocardial infarction
  2. Blood pressure systolic increased
  3. Bradycardia
  4. Heart rate decreased
  5. Rheumatoid vasculitis

Common Sulfatrim and Naprosyn drug interactions by age *:

0-1:

  1. Abdominal discomfort
  2. Abdominal pain upper
  3. Abnormal loss of weight
  4. Arthropathy
  5. Deafness
  6. Deafness transitory
  7. Decreased appetite
  8. Dizziness
  9. Drug hypersensitivity
  10. Ear infection

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Rheumatoid vasculitis

60+:

  1. Deafness
  2. Decreased appetite
  3. Weight decreased
  4. Abdominal discomfort
  5. Abdominal pain upper
  6. Arthropathy
  7. Drug hypersensitivity
  8. Gastrointestinal pain
  9. Abnormal loss of weight
  10. Deafness transitory

Common conditions people have *:

  1. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 42 people, 100.00%
  2. Mobility Decreased (ability to move is reduced): 23 people, 54.76%
  3. Joint Stiffness: 23 people, 54.76%
  4. Polyarteritis Nodosa (progressive disease of connective tissue): 3 people, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Sulfatrim and Naprosyn?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Sulfatrim and Naprosyn:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Sulfatrim side effects:

Browse all side effects of Sulfatrim:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Naprosyn side effects:

Browse all side effects of Naprosyn:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Sulfatrim interactions:

Browse all interactions between Sulfatrim and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Naprosyn interactions:

Browse all interactions between Naprosyn and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on sulfamethoxazole; trimethoprim and naproxen (the active ingredients of Sulfatrim and Naprosyn, respectively), and Sulfatrim and Naprosyn (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Sulfatrim and Naprosyn.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2023 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.